Acute Presynaptic Inhibition by Doxorubicin of Negative Chrono- and Inotropic Responses to Parasympathetic Nerve Stimulation in Isolated, Blood-Perfused Dog Atrium

Journal of Cardiovascular Pharmacology

Volumn 27, Issue 1, 1996, Pages 37-41

  Hoyano, Yuji ^a   Furukawa, Yasuyuki ^a   Oguchi, Takeshi ^a   Kasama, Miho ^a   Imamura, Hiroshi ^a   Chiba, Shigetoshi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chronotropism; Dog heart; Doxorubicin; Inotropism; Parasympathetic nervous system

Indexed keywords

ACETYLCHOLINE; DOXORUBICIN; NORADRENALIN;

ANIMAL TISSUE; ARTICLE; AUTONOMIC NERVE; CHOLINERGIC TRANSMISSION; CHRONOTROPISM; DOG; DOSE RESPONSE; HEART ATRIUM; INOTROPISM; NERVE FUNCTION; NERVE STIMULATION; NONHUMAN; PRESYNAPTIC INHIBITION; PRIORITY JOURNAL;

ACETYLCHOLINE; ADRENERGIC ALPHA-AGONISTS; ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ATRIAL FUNCTION; DOGS; DOXORUBICIN; FEMALE; HEART ATRIA; MALE; MYOCARDIAL CONTRACTION; MYOCARDIAL REPERFUSION; NOREPINEPHRINE; PARASYMPATHETIC NERVOUS SYSTEM; SINOATRIAL NODE;

EID: 0030050907     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199601000-00007     Document Type: Article

References (38)

1. Blum RH, Carter SK. Adriamycin: a new anticancer drug with significant clinical activity. Ann Intern Med 1974;80: 249-59.
2. Rosenberg S, Tepper J, Glatstein E, et al. Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcoma of extremities. Cancer 1983;52:424-34.
3. Torti FM, Aston D, Lum BL, et al. Weekly doxorubicin in endcrine refractory carcinoma of the prostate. J Clin Oncol 1983;1:477-82.
4. Lefrak EA, Pitha J, Rosenhein S, Gottlieb JA. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 1973;32:302-14.
5. Bristow MR, Mason JW, Billingham ME, Daniels JR. Dose-effect and structure-function relationships in doxorubicin cardiomyopathy. Am Heart J 1981;102:709-18.
6. Steinberg JS, Cohen AJ, Wasserman AG, Cohen P, Ross AM. Acute arrhythmogenicity of doxorubicin administration. Cancer 1987;60:1213-8.
7. Höfling B, Bolte HD. Acute negative inotropic effect of adriamycin (doxorubicin). Naunyn Schmiedebergs Arch Pharmacol 1981;317:252-6.
8. Ditchey RV, LeWinter MM, Higgins CB. Acute effects of doxorubicin (adriamycin) on left ventricular function in dogs. Int J Cardiol 1984;6:341-53.
9. Miwa N, Kanaide H, Meno H, Nakamura M. Adriamycin and altered membrane functions in rat hearts. Br J Exp Pathol 1986;67:747-55.
10. Bossa R, Favalli L, Galatulas I, Lanza E. Effect of adriamycin on myocardial contractility and on the action of antibiotic ionophores. Anticancer Res 1988;8:553-5.
11. Hagane K, Akera T, Berlin JR. Doxorubicin: mechanism of cardiodepressant action in guinea pigs. J Pharmacol Exp Ther 1988;246:655-61.
12. Combs AB, Acosta D. Toxin mechanisms of the heart: a review. Toxicol Pathol 1990;18:583-96.
13. Olson RD, Mushlin PS. Doxorubicin cardiotoxicity: analysis of prevailing hypotheses. FASEB J 1990;4:3076-86.
14. Cho ES. Toxic effects of adriamycin on the ganglia of the peripheral nervous system: a neuropathological study. J Neuropathol Exp Neurol 1977;36:907-15.
15. Cho ES, Spencer PS, Jortner BS, Schaumburg HH. A single intravenous injection of doxorubicin (adriamycin) induces sensory neuronopathy in rats. Neurotoxicology 1980;1:583-91.
16. Jortner BS, Cho ES. Neurotoxicity of adriamycin in rats: a low-dose effect. Cancer Treat Rep 1980;64:257-61.
17. Bronson RT, Henderson IC, Fixler H. Ganglioneuropathy in rabbits and a rhesus monkey due to high cumulative doses of doxorubicin. Cancer Treat Rep 1982;66:1349-55.
18. Eddy EL. Neuronal loss from cervical dorsal root ganglia in adriamycin induced peripheral neuropathy-a quantitative study. Anat Anz 1983;153:83-90.
19. Chiba S, Kimura T, Hashimoto K. Muscarinic suppression of nicotinic action of acetylcholine on the isolated, blood-perfused atrium of the dog. Naunyn Schmiedebergs Arch Pharmacol 1975;289:315-25.
20. Furukawa Y, Kobayashi M, Chiba S. A pharmacologic analysis of chronotropic and inotropic responses to direct electrical stimulation of the isolated, blood-perfused canine atrium. Jpn Heart J 1980;21:873-82.
21. Furukawa Y, Wallick DW, Carlson MD, Martin PJ. Cardiac electrical responses to vagal stimulation of fibers to discrete cardiac regions. Am J Physiol 1990;258:H1112-8.
22. Temma K, Akera T, Chugun A, Ohashi M, Yabuki M, Kondo H. Doxorubicin: an antagonist of muscarinic receptors in guinea pig heart. Eur J Pharmacol 1992;220:63-9.
23. Politi PM, Rothlin RP, Pinto JE. Acute effects of doxorubicin on chronotropic and inotropic mechanisms in guinea pig atria. Cancer Treat Rep 1985;69:859-65.
24. Rasmussen IM, Schou HS, Hermansen K. Cardiotoxic effects and the influence on the beta-adrenoceptor function of doxorubicin (Adriamycin) in the rat. Pharmacol Toxicol 1989;65:69-72.
25. Mettler FP, Young DM, Ward JM. Adriamycin-induced cardiotoxicity (cardiomyopathy and congestive heart failure) in rats. Cancer Res 1977;37:2705-13.
26. Lee YC, Byfield JE. Induction of DNA degradation in vivo by Adriamycin. J Natl Cancer Inst 1976;57:221-4.
27. Brown JR. Adriamycin and related anthracycline antibiotics. Prog Med Chem 1978;15:125-64.
28. Bigotte L, Arvidson B, Olsson Y. Cytofluorescence localization of adriamycin in the nervous system: II. Distribution of the drug in the somatic and autonomic perpheral nervous systems of normal adult mice after intravenous injection. Acta Neuropathol (Berl) 1982;57:130-6.
29. Olson RD, Boerth RC, Gerber JD, Nies AS. Mechanism of adriamycin cardiotoxicity: evidence for oxidative stress. Life Sci 1981;29:1393-401.
30. Doroshow JH. Effect of anthracycline antibiotics on oxygen radical formation in rat heart. Cancer Res 1983;43:460-72.
31. Thornalley PJ, Dodd NJ. Free radical production from normal and adriamycin-treated rat cardiac sarcosomes. Biochem Pharmacol 1985;34:669-74.
32. Gaudiano G, Koch TH. Redox chemistry of anthracycline antitumor drugs and use of captodative radicals as tools for its elucidation and control. Chem Res Toxicol 1991;4:2-16.
33. LeBel CP, Bondy SC. Oxygen radicals: common mediators of neurotoxicity. Neurotoxicol Teratol 1991;13:341-6.
34. Michikawa M, Lim KT, McLarnon JG, Kim SU. Oxygen radical-induced neurotoxicity in spinal cord neuron cultures. J Neurosci Res 1994;37:62-70.
35. Monti E, Piccinini F, Favalli L, Villani F. Role of the fast-exchanging calcium compartment in the early cardiotoxicity of anthracycline analogs. Biochem Pharmacol 1983;32: 3303-6.
36. Harris RN, Doroshow JH. Effect of doxorubicin-enhanced hydrogen peroxide and hydroxyl radical formation on calcium sequestration by cardiac sacroplasmic reticulum. Biochem Biophys Res Commun 1985;130:739-45.
37. Santone KS, Oakes SG, Taylor SR, Powis G. Anthracycline-induced inhibition of a calcium action potential in differentiated murine neuroblastoma cells. Cancer Res 1986;46: 2659-64.
38. Said AA, Matsuki N, Kasuya Y. Effects of aminoglycoside antibiotics on cholinergic autonomic nervous transmission. Pharmacol Toxicol 1995;76:128-32.